Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Ionis Pharmaceuticals Stock Quote

Ionis Pharmaceuticals (NASDAQ: IONS)

Price as of March 1, 2024, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ionis Pharmaceuticals Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
IONS +26.95% -34.77% -8.18% +355%
S&P +29.03% +83.23% +12.86% +1,279%

Ionis Pharmaceuticals Company Info

Ionis Pharmaceuticals is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

News & Analysis

The Fool has written over 300 articles on Ionis Pharmaceuticals.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.